Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Suven Pharmaceuticals has informed that the CRISIL has assigned/ reaffirmed the ratings to the Bank facilities of the Company as per letter received on February 28, 2025. The said letter is annexed.
The above information is a part of company’s filings submitted to BSE.